 | Intra-Cellular Therapies Inc. | |||
| NMS : ITCI || Location: United States | ||||
$72.65+0.65 (+0.9%) |
0.35 M | 71.73 - 74.56 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.465 M |
| March 15, 2024 | 3.307 M |
| Feb. 29, 2024 | 3.695 M |
| Feb. 15, 2024 | 3.859 M |
| Jan. 31, 2024 | 4.066 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.45 | -0.30 | 33.55% |
| 09/30/2023 | -0.58 | -0.25 | 56.70% |
| 06/30/2023 | -0.60 | -0.45 | 25.25% |
| 03/31/2023 | -0.62 | -0.46 | 25.60% |
| 12/31/2022 | -0.60 | -0.45 | 25.52% |
ITCI Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 96.807M | Shares Float | 94.593M |
| Short Float | 3.465M | Market Cap | 6970.10M |
| Institution ownership | 99.05% | Insider ownership | 2.511% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.46 | Forward EPS | 1.14 |